Heart failure hospitalization reduction and cost savings achieved by improved delivery of effective biventricular pacing: economic implications of the OLE study under the US setting

References

• Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3:7–11. doi:10.15420/cfr.2016:25:228785469
   PubMedGoogle Scholar
• Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–619. doi:10.1161/HHF.0b013e318291329a23616602
   PubMed Web of Science ®Google Scholar
• Jackson SL, Tong X, King RJ, Loustalot F, Hong Y, Ritchey MD. National burden of heart failure events in the United States, 2006 to 2014. Circ Heart Fail. 2018;11:e004873. doi:10.1161/CIRCHEARTFAILURE.117.00487330562099
   PubMed Web of Science ®Google Scholar
• Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J. 2002;23:1867–1876.12445536
   PubMed Web of Science ®Google Scholar
• Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34:2281–2329. doi:10.1093/eurheartj/eht15023801822
   PubMed Web of Science ®Google Scholar
• Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1–e62. doi:10.1016/j.jacc.2008.02.03218498951
   PubMedGoogle Scholar
• Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385–e484. doi:10.1161/CIRCULATIONAHA.106.17823316935995
   PubMed Web of Science ®Google Scholar
• Cleland JG, Abraham WT, Linde C, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013;34:3547–3556. doi:10.1093/eurheartj/eht29023900696
   PubMed Web of Science ®Google Scholar
• Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JG. Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction – a systematic review and meta-analysis. Eur J Heart Fail. 2006;8:433–440. doi:10.1016/j.ejheart.2005.11.01416507349
   PubMed Web of Science ®Google Scholar
• Linde C, Abraham WT, Gold MR, et al. Predictors of short-term clinical response to cardiac resynchronization therapy. Eur J Heart Fail. 2017;19:1056–1063. doi:10.1002/ejhf.79528295869
   PubMed Web of Science ®Google Scholar
• Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol. 2002;40:1615–1622.12427414
   PubMed Web of Science ®Google Scholar
• Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol. 2003;91:684–688.12633798
   PubMed Web of Science ®Google Scholar
• Daubert C, Behar N, Martins RP, Mabo P, Leclercq C. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. Eur Heart J. 2017;38:1463–1472. doi:10.1093/eurheartj/ehw27027371720
   PubMed Web of Science ®Google Scholar
• Mullens W, Grimm RA, Verga T, et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009;53:765–773. doi:10.1016/j.jacc.2008.11.02419245967
   PubMed Web of Science ®Google Scholar
• Hayes DL, Boehmer JP, Day JD, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm. 2011;8:1469–1475. doi:10.1016/j.hrthm.2011.04.01521699828
   PubMed Web of Science ®Google Scholar
• Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol. 2009;53:355–360. doi:10.1016/j.jacc.2008.09.04319161886
   PubMed Web of Science ®Google Scholar
• Ruwald AC, Kutyifa V, Ruwald MH, et al. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling. Eur Heart J. 2015;36:440–448. doi:10.1093/eurheartj/ehu29425112662
   PubMedGoogle Scholar
• Hernandez-Madrid A, Facchin D, Klepfer RN, et al. Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for Efficacy analysis of CRT (OLE CRT) study. Heart Rhythm. 2017;14:541–547. doi:10.1016/j.hrthm.2017.01.02228104482
   PubMedGoogle Scholar
• Ghosh S, Stadler RW, Mittal S. Automated detection of effective left-ventricular pacing: going beyond percentage pacing counters. Europace. 2015;17:1555–1562. doi:10.1093/europace/euv06225862307
   PubMedGoogle Scholar
• Krum H, Lemke B, Birnie D, et al. A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial. Am Heart J. 2012;163:747–752 e741. doi:10.1016/j.ahj.2012.02.00722607850
   PubMed Web of Science ®Google Scholar
• Chung ES, Singh JP, Martin DO, et al. Clinical and economic value of maximizing response to cardiac resynchronization therapy (CRT): evidence from five randomized controlled trials. Circulation. 2014;130:A16318 Abstract.
   Google Scholar
• Mealing S, Woods B, Hawkins N, et al. Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure. Heart. 2016;102:1742–1749. doi:10.1136/heartjnl-2015-30888327411837
   PubMed Web of Science ®Google Scholar
• Hayes DL, Monteiro JV, Tsintzos SI, Eggington S, Mittal S. Abstract The relationship between percentage left ventricular (LV) pacing and cardiac resynchronization therapy (CRT) outcomes: each percentage matters. Heart Rhythm. 2016;13:S427–S514.
   Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. Cardiac resynchronization-heart failure study I. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–1549. doi:10.1056/NEJMoa05049615753115
   PubMed Web of Science ®Google Scholar
• Calvert MJ, Freemantle N, Yao G, et al. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J. 2005;26:2681–2688. doi:10.1093/eurheartj/ehi66216284203
   PubMed Web of Science ®Google Scholar
• Feldman AM, de Lissovoy G, Bristow MR, et al. Cost effectiveness of cardiac resynchronization therapy in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial. J Am Coll Cardiol. 2005;46:2311–2321. doi:10.1016/j.jacc.2005.08.03316360064
   PubMed Web of Science ®Google Scholar
• Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization reverses remodeling in systolic left ventricular dysfunction). Eur Heart J. 2011;32:1631–1639. doi:10.1093/eurheartj/ehq40821112898
   PubMed Web of Science ®Google Scholar
• Gasparini M, Galimberti P, Ceriotti C. The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy. Curr Opin Cardiol. 2013;28:50–54. doi:10.1097/HCO.0b013e32835b0b1723196776
   PubMedGoogle Scholar
• Varma N, Stadler RW, Ghosh S, Kloppe A. Influence of automatic frequent pace-timing adjustments on effective left ventricular pacing during cardiac resynchronization therapy. Europace. 2017;19:831–837. doi:10.1093/europace/euw10827230561
   PubMedGoogle Scholar
• Martin DO, Lemke B, Birnie D, et al. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm. 2012;9:1807–1814. doi:10.1016/j.hrthm.2012.07.00922796472
   PubMed Web of Science ®Google Scholar